Premier Value by is a Otc medication manufactured, distributed, or labeled by Chain Drug Consortium, Taro Pharmaceuticals U.S.A., Inc., Taro Pharmaceuticals Inc.. Drug facts, warnings, and ingredients follow.
PREMIER VALUE
TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin sulfate, and polymyxin b sulfate ointment |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - Chain Drug Consortium (101668460) |
Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(68016-500) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PREMIER VALUE 78208206 3357001 Live/Registered |
PHARMACY VALUE ALLIANCE, LLC 2003-01-29 |
PREMIER VALUE 75164203 2113837 Dead/Cancelled |
MINNESOTA FIRE AND CASUALTY COMPANY 1996-09-11 |